肺癌作为全球癌症头号杀手，每年引起发病约210万人，超过180万人死亡。GPT等AI技术为肺癌防治带来曙光，可通过NLP高效精准赋能咨询与诊疗建议，促进知识共享与医疗水平的均衡提升，为患者提供个性化健康指导与心理慰藉。核心技术原理为“四改”：（1）改清洗数据为数据精选；（2）改简单咨询为直面分身；（3）改盲目宠信为质控核对；（4）改单纯循证加大医经验。临床验证与效果：BAIMGPT与DeepSeek对照研究显示，BAIMGPT在亲切感、安全感、问题理解力、回答精准性等方面展现显著优势。其独特的技术架构和“四改创新点”确保了专业性和准确性，为AI辅助诊断系统的未来发展提供了重要参考。实际应用场景与价值：BAIMGPT在肺癌筛查、肺结节咨询与管理、诊断分期、治疗方案制定及术后管理等关键环节均可展现显著价值。通过智能影像分析，优化诊疗流程，降低医疗成本，提高资源利用效率。多学科协作创新：BAIMGPT的成功实施依靠医学专家、信息工程师、数据分析专家等多领域人才协同工作，共同构建适用性强、易于操作的知识体系。通过跨学科知识整合，提升肺癌筛查和评估的效率及准确性，优化患者咨询体验。用户体验优化：BAIMGPT在界面设计、亲切感、安全感、视觉赋能、语音交互、可及性及便捷性等方面进行了全面优化，确保用户能够快速上手并生成高质量报告，增强患者信心，优化诊疗体验。法律法规与伦理：BAIMGPT已获得国家知识产权局授予的注册商标，并通过中山医院伦理委员会批准。与国际元宇宙医学协会和中国肺癌防治联盟合作，确保技术的合法性和专业性。同时，BAIMGPT严格遵循伦理要求，减少人为偏见，确保系统运行的公正性和透明性。发展前景与展望：随着AI技术的快速发展，BAIMGPT将在肺癌筛查、评估和诊疗领域展现潜力。未来可通过结合其他影像技术、优化专病模型精准性、拓展实现疾病进展预测等功能，进一步提升系统效率与准确性。BAIMGPT有望成为推动公共健康事业发展的重要力量，助力实现“健康中国”重要目标。

As the number one killer of cancer in the world, lung cancer causes about 2.1 million cases and more than 1.8 million deaths every year. AI technologies such as GPT have brought hope to the prevention and treatment of lung cancer, which can efficiently and accurately empower consultation and diagnosis and treatment suggestions through NLP, promote knowledge sharing and balanced improvement of medical standards, and provide patients with personalized health guidance and psychological comfort. The core technical principle is“ four changes”. (1) Change the cleaning data to data selection; (2) Change simple consultation to face the digital expert; (3) Change blind favor to quality control and verification; (4) Change to simply evidence-based and increase medical experience. A controlled study between BAIMGPT and DeepSeek has shown significant advantages in terms of intimacy, security, question understanding, and answer accuracy. Its unique technical architecture and“ four innovations” ensure professionalism and accuracy and provide an important reference for the future development of AI-assisted diagnosis systems. BAIMGPT can show significant value in key links such as lung cancer screening, pulmonary nodule consultation and management, diagnosis and staging, 

treatment plan formulation and postoperative management. Through intelligent image analysis, the diagnosis and treatment process can be optimized, medical costs can be reduced, and resource utilization efficiency can be improved. The successful implementation of BAIMGPT relies on the collaborative work of medical experts, information engineers, data analysis experts and other talents in multiple fields to jointly build a highly applicable and easy-to-operate knowledge system. Through the integration of interdisciplinary knowledge, the efficiency and accuracy of lung cancer screening and evaluation are improved, and the patient consultation experience is optimized. User experience optimization: BAIMGPT has been comprehensively optimized in terms of interface design, intimacy, sense of security, visual empowerment, voice interaction, accessibility and convenience, etc., to ensure that users can quickly get started and generate high-quality reports, enhance patient confidence, and optimize the diagnosis and treatment experience. BAIMGPT has been granted a registered trademark by the State Intellectual Property Office and approved by the Ethics Committee of Zhongshan Hospital. Cooperate with the International Metaverse Medical Association and the China Lung Cancer Prevention and Control Alliance to ensure the legitimacy and professionalism of the technology. At the same time, BAIMGPT strictly adheres to ethical requirements, reduces human bias, and ensures the fairness and transparency of the operation of the system. With the rapid development of AI technology, BAIMGPT will show potential in the field of lung cancer screening, evaluation and diagnosis and treatment. In the future, the efficiency and accuracy of the system can be further improved by combining other imaging technologies, optimizing the accuracy of disease-specific models, and expanding the functions of disease progression prediction. BAIMGPT is expected to become an important force in promoting the development of public health and helping to achieve the important goal of“ Healthy China”